Chorioamnionitis Guidelines

Updated: May 08, 2018
  • Author: Fayez M Bany-Mohammed, MD; Chief Editor: Ted Rosenkrantz, MD  more...
  • Print
Guidelines

Guidelines Summary

The Centers for Disease Control and Prevention (CDC) continues to publish updated guidelines for prevention of perinatal GBS disease; the most recent one was published in 2010, [170]  with an update in 2012. [171]

Although it was not considered a consensus development conference, in 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) convened a panel of experts from the Society for Maternal-Fetal Medicine (SMFM), the American College of Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics (AAP) for a workshop that issued a report on the evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis. [2] The panel noted that the term "chorioamnionitis" has been used to label a heterogeneous array of conditions characterized by intrauterine infection, inflammation, or both, with a consequent great variation in clinical practice for mothers and their newborns. Therefore, the panel proposed to replace the term "chorioamnionitis" with a more general, descriptive term: “intrauterine inflammation or infection or both,” abbreviated as “triple I.” The panel also proposed a classification (see the table under Diagnostic Considerations) for triple I as well as recommended approaches for the evaluation and management of pregnant women and their newborns with a diagnosis of triple I. Furthermore, the panel indicated the importance of recognizing that an isolated maternal fever is not synonymous with chorioamnionitis.